Sun Pharma Advanced Research Company Limited (NSE:SPARC)
India · Delayed Price · Currency is INR | Market Cap | 69.19B +51.8% |
| Revenue (ttm) | 18.79B +2,518.5% |
| Net Income | 15.53B |
| EPS | 47.86 |
| Shares Out | 324.52M |
| PE Ratio | 4.45 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 606,369 |
| Open | 216.99 |
| Previous Close | 216.98 |
| Day's Range | 211.00 - 217.03 |
| 52-Week Range | 108.00 - 289.00 |
| Beta | 0.66 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 10, 2026 |
About NSE:SPARC
Sun Pharma Advanced Research Company Limited engages in the research and development of pharmaceutical products in India and internationally. It develops Sezaby, a benzyl alcohol and propylene glycol free formulation of phenobarbital sodium injection for the treatment of neonatal seizures; SPARC-121, a novel topical agent for the treatment of Alopecia Areata; and SPARC-122, an anti-MUC1 ADC for treatment of multiple cancer indications. The company is also involved in the development of PDP-716 for treatment of open-angle glaucoma. Sun Pharma Ad... [Read more]
Financial Performance
Financial StatementsNews
Sparc to hold 21st AGM on August 10, 2026 via video conference
Sun Pharma Advanced Research Company (SPARC) has announced that its 21st Annual General Meeting (AGM) will be conducted on Monday, August 10, 2026, at 04:30 P.M. (IST). The meeting will…
Sun Pharma Advanced Research Company receives Rs 149.99 crore for warrant allotment
Sun Pharma Advanced Research Company (SPARC) has received a substantial sum of ₹149,99,64,500 from Shanghvi Finance Private Limited towards the preferential allotment of warrants. This financial trans...
52-week high stocks today: Apollo Micro up 8.69%, NRB Bearings gains 5.28%, Angel One rises 2.11%; HFCL, SPARC and Timex hit fresh highs
Apollo Micro Systems, NRB Bearings, Angel One, Gujarat Fluorochemicals (GFCL), Sun Pharma Advanced Research Company (SPARC), and Timex Group India were among the stocks hitting fresh 52-week highs dur...
Sun Pharma Advanced Research partner receives FDA response on PDP-716 application
Sun Pharma Advanced Research Company (SPARC) has announced that its licensing partner, Ocuvex Therapeutics Inc., has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administratio...
Why are Sun Pharma Advanced shares up over 14% today? Explained
Shares of Sun Pharma Advanced Research Company surged more than 14% on Monday after the company reported a sharp turnaround in its March quarter earnings, supported by exceptional gains and…
Sun Pharma Advanced Research Company Quarterly report: Q4 2026
Sun Pharma Advanced Research Company has published its Q4 2026 quarterly earnings report on May 18, 2026.
Sun Pharma Advanced Research Company sells priority review voucher for $195 million
Sun Pharma Advanced Research Company (SPARC) has announced the sale of its Rare Paediatric Disease Priority Review Voucher (PRV) for a substantial $195 million. The transaction, which is subject to…
Why Sun Pharma shares are falling nearly 3% today? Epxlained
Shares of Sun Pharma Advanced Research Company declined over 2 percent in Monday’s session, trading near Rs 121, after fresh concerns emerged following a major policy move by Donald Trump…
Sun Pharma Advanced Research Company Quarterly report: Q3 2026
Sun Pharma Advanced Research Company has published its Q3 2026 quarterly earnings report on February 9, 2026.
Sun Pharma receives FDA Rare Pediatric Disease Priority Review Voucher for Sezaby
Sun Pharma Advanced Research Company Ltd. (SPARC) announced that the United States Food and Drug Administration (FDA) has granted a...
Sun Pharma Advanced Research Company Transcript: R&D Day 2026
Pipeline is now focused on oncology and immunology, with lead programs in MUC1 ADC and SCD153 advancing through clinical trials. Cost optimization and partnerships support progress, while key regulatory and financial milestones are expected over the next year.
Sun Pharma Advanced Research Company Slides: FY 2026
Sun Pharma Advanced Research Company has posted slides in relation to its FY 2026 quarterly earnings report, which was published on January 8, 2026.
Sparc shares surge 27% in 2 days – Know the reason behind the rally
Sun Pharma Advanced Research Company Ltd. (NSE: SPARC) extended its rally on Wednesday, December 3, with the stock trading at...
Why are SPARC shares up 20% today; Explained
Sun Pharma Advanced Research Company Ltd. (NSE: SPARC), commonly referred to as SPARC, saw its shares hit 20% today after...
Sun Pharma Advanced Research Company Quarterly report: Q2 2026
Sun Pharma Advanced Research Company has published its Q2 2026 quarterly earnings report on November 10, 2025.
SPARC to announce Q2 results on November 10
Sun Pharma Advanced Research Company Ltd (SPARC) has notified the exchanges that its Board of Directors will meet on Monday,...
Sun Pharma Advanced Research Q1 Results: Net loss narrows to Rs 51.8 crore, Revenue drops 42.6% YoY
Sun Pharma Advanced Research Company (SPARC) reported a consolidated net loss of Rs 51.8 crore for the quarter ended June 30, 2025 (Q1 FY26), significantly narrowing from the loss of Rs 95.9 crore in ...
Sun Pharma Advanced Research Company Quarterly report: Q1 2026
Sun Pharma Advanced Research Company has published its Q1 2026 quarterly earnings report on August 3, 2025.
SPARC shares drop nearly 20% after key drug trial fails
Shares of Sun Pharma Advanced Research Company (SPARC) declined sharply by nearly 20% after the company announced the discontinuation of clinical trials for its experimental drug Vibozilimod (SCD-044)...
SPARC shares fall over 13% in trade today: Details here
Shares of Sun Pharma Advanced Research Company Ltd (SPARC) declined sharply in Wednesday’s trading session, falling over 13% intraday. As of 9:27 AM, the shares were trading 13.32% lower at Rs 169.19....
Sun Pharma Advanced Research Company Annual report: Q4 2025
Sun Pharma Advanced Research Company has published its Q4 2025 annual report on May 19, 2025.
Sun Pharma Advanced Research Company Quarterly report: Q4 2025
Sun Pharma Advanced Research Company has published its Q4 2025 quarterly earnings report on May 19, 2025.
Stock Market Today: Rajesh Exports, SCI, RHIM, SPARC, and KEC among top 5 gainers on March 20, 2025
The Indian stock market witnessed significant gains on March 20, 2025, with several stocks rallying strongly. Among them, Rajesh Exports, Shipping Corporation of India (SCI), RHI Magnesita (RHIM), Sun...
Sun Pharma Advanced Research Company Quarterly report: Q3 2025
Sun Pharma Advanced Research Company has published its Q3 2025 quarterly earnings report on February 10, 2025.
Sun Pharma Advanced Research Company Transcript: Status Update
Portfolio is now focused on oncology and immunology, prioritizing SCD-153 and SBO-154, with flexible business models and cost controls in place. Multiple short-term cash catalysts are being pursued, including litigation, licensing, and regulatory milestones, while key clinical programs advance toward major data readouts.